Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.
Código da empresaCODX
Nome da EmpresaCo-Diagnostics Inc
Data de listagemJul 12, 2017
CEOMr. Dwight H. Egan
Número de funcionários132
Tipo de títulosOrdinary Share
Fim do ano fiscalJul 12
Endereço2401 S. Foothill Dr. Suite D
CidadeSALT LAKE CITY
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal84109
Telefone18014381036
Sitehttp://codiagnostics.com/
Código da empresaCODX
Data de listagemJul 12, 2017
CEOMr. Dwight H. Egan
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.

Sem dados